213 related articles for article (PubMed ID: 31001115)
1. Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.
Vitale A; Cavalli G; Colafrancesco S; Priori R; Valesini G; Argolini LM; Baldissera E; Bartoloni E; Cammelli D; Canestrari G; Sota J; Cavallaro E; Massaro MG; Ruscitti P; Cipriani P; De Marchi G; De Vita S; Emmi G; Ferraccioli G; Frassi M; Gerli R; Gremese E; Iannone F; Lapadula G; Lopalco G; Manna R; Mathieu A; Montecucco C; Mosca M; Piazza I; Piga M; Pontikaki I; Romano M; Rossi S; Rossini M; Silvestri E; Stagnaro C; Talarico R; Tincani A; Viapiana O; Vitiello G; Galozzi P; Sfriso P; Gaggiano C; Rigante D; Dagna L; Giacomelli R; Cantarini L
Front Pharmacol; 2019; 10():296. PubMed ID: 31001115
[No Abstract] [Full Text] [Related]
2. Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.
Sota J; Rigante D; Ruscitti P; Insalaco A; Sfriso P; de Vita S; Cimaz R; Lopalco G; Emmi G; La Torre F; Fabiani C; Olivieri AN; Cattalini M; Cammelli D; Gallizzi R; Alessio M; Manna R; Viapiana O; Frassi M; Pardeo M; Maier A; Salvarani C; Talarico R; Mosca M; Colafrancesco S; Priori R; Maggio MC; Gaggiano C; Grosso S; De Benedetti F; Vitale A; Giacomelli R; Cantarini L
Front Pharmacol; 2019; 10():918. PubMed ID: 31507416
[No Abstract] [Full Text] [Related]
3. Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.
Colafrancesco S; Priori R; Valesini G; Argolini L; Baldissera E; Bartoloni E; Cammelli D; Canestrari G; Cantarini L; Cavallaro E; Cavalli G; Cerrito L; Cipriani P; Dagna L; Marchi G; Vita S; Emmi G; Ferraccioli G; Frassi M; Galeazzi M; Gerli R; Giacomelli R; Gremese E; Iannone F; Lapadula G; Lopalco G; Manna R; Mathieu A; Montecucco C; Mosca M; Piazza I; Piga M; Pontikaki I; Romano M; Rossi S; Rossini M; Ruscitti P; Silvestri E; Stagnaro C; Talarico R; Tincani A; Viapiana O; Vitiello G; Fabris F; Bindoli S; Punzi L; Galozzi P; Sfriso P
Front Pharmacol; 2017; 8():369. PubMed ID: 28659802
[No Abstract] [Full Text] [Related]
4. Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes.
Vitale A; Cavalli G; Ruscitti P; Sota J; Colafrancesco S; Priori R; Valesini G; Argolini LM; Baldissera E; Bartoloni E; Cammelli D; Canestrari G; Cavallaro E; Massaro MG; Cipriani P; De Marchi G; De Vita S; Emmi G; Frassi M; Gerli R; Gremese E; Iannone F; Fornaro M; Paladini A; Lopalco G; Manna R; Mathieu A; Montecucco C; Mosca M; Piazza I; Piga M; Pontikaki I; Romano M; Rossi S; Rossini M; Silvestri E; Stagnaro C; Talarico R; Frediani B; Tincani A; Viapiana O; Vitiello G; Galozzi P; Sfriso P; Gaggiano C; Grosso S; Rigante D; Dagna L; Giacomelli R; Cantarini L
Front Med (Lausanne); 2020; 7():42. PubMed ID: 32154255
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry.
Sota J; Vitale A; Lopalco G; Pereira RMR; Giordano HF; Antonelli IPB; Makowska J; Brzezińska O; Lewandowska-Polak A; Ruscitti P; Cipriani P; Cola ID; Govoni M; Ruffili F; Sfikakis PP; Laskari K; Ragab G; Hussein MA; Gentileschi S; Gaggiano C; La Torre F; Maier A; Emmi G; Marino A; Ciccia F; Sfriso P; Maggio MC; Bartoloni E; Lomater C; Hegazy MT; Tektonidou M; Dagostin MA; Opinc A; Sebastiani GD; Giacomelli R; Giudice ED; Olivieri AN; Tufan A; Kardas RK; Nuzzolese R; Cardinale F; Więsik-Szewczyk E; Veronica P; Tarsia M; Iannone F; Della Casa F; Fabiani C; Frediani B; Balistreri A; Rigante D; Cantarini L
Semin Arthritis Rheum; 2022 Dec; 57():152089. PubMed ID: 36063578
[TBL] [Abstract][Full Text] [Related]
6. Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry.
Vitale A; Caggiano V; Maggio MC; Lopalco G; Emmi G; Sota J; La Torre F; Ruscitti P; Bartoloni E; Conti G; Fabiani C; Mattioli I; Gaggiano C; Cardinale F; Dagna L; Campochiaro C; Giacomelli R; Balistreri A; Laskari K; Tufan A; Ragab G; Almaghlouth IA; Więsik-Szewczyk E; Pereira RM; Frediani B; Iannone F; Sfikakis PP; Cantarini L
Front Med (Lausanne); 2022; 9():1071732. PubMed ID: 36619631
[TBL] [Abstract][Full Text] [Related]
7. Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease.
Vitale A; Berlengiero V; Sota J; Ciarcia L; Ricco N; Barneschi S; Mourabi M; Lopalco G; Marzo C; Bellisai F; Iannone F; Frediani B; Cantarini L
Mediators Inflamm; 2020; 2020():8054961. PubMed ID: 33122969
[TBL] [Abstract][Full Text] [Related]
8. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.
Kalyoncu U; Solmaz D; Emmungil H; Yazici A; Kasifoglu T; Kimyon G; Balkarli A; Bes C; Ozmen M; Alibaz-Oner F; Erten S; Cagatay Y; Cetin GY; Yilmaz S; Yildiz F; Pamuk ON; Kucuksahin O; Kilic L; Yazisiz V; Karadag O; Koca SS; Hayran M; Akar S; Aksu K; Akkoc N; Keser G; Gonullu E; Kisacik B; Onat AM; Soy M; Inanc N; Direskeneli H; Sayarlioglu M; Erken E; Turgay M; Cefle A; Ertenli I; Pay S
J Autoimmun; 2016 May; 69():59-63. PubMed ID: 26970681
[TBL] [Abstract][Full Text] [Related]
9. Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.
Sota J; Insalaco A; Cimaz R; Alessio M; Cattalini M; Gallizzi R; Maggio MC; Lopalco G; La Torre F; Fabiani C; Pardeo M; Olivieri AN; Sfriso P; Salvarani C; Gaggiano C; Grosso S; Bracaglia C; De Benedetti F; Rigante D; Cantarini L
Front Pharmacol; 2018; 9():1526. PubMed ID: 30670972
[No Abstract] [Full Text] [Related]
10. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy.
Giampietro C; Ridene M; Lequerre T; Costedoat Chalumeau N; Amoura Z; Sellam J; Sibilia J; Bourgeois P; Fautrel B;
Arthritis Care Res (Hoboken); 2013 May; 65(5):822-6. PubMed ID: 23225779
[TBL] [Abstract][Full Text] [Related]
11. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
Colafrancesco S; Manara M; Bortoluzzi A; Serban T; Bianchi G; Cantarini L; Ciccia F; Dagna L; Govoni M; Montecucco C; Priori R; Ravelli A; Sfriso P; Sinigaglia L;
Arthritis Res Ther; 2019 Dec; 21(1):275. PubMed ID: 31829244
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's Disease.
Vitale A; Caggiano V; Sfikakis PP; Dagna L; Lopalco G; Ragab G; La Torre F; Almaghlouth IA; Maggio MC; Sota J; Tufan A; Hinojosa-Azaola A; Iannone F; Loconte R; Laskari K; Direskeneli H; Ruscitti P; Morrone M; Mayrink Giardini HA; Panagiotopoulos A; Di Cola I; Martín-Nares E; Monti S; De Stefano L; Kardas RC; Duran R; Campochiaro C; Tomelleri A; Alabdulkareem AM; Gaggiano C; Tarsia M; Bartoloni E; Romeo M; Hussein MA; Laymouna AH; Parente de Brito Antonelli I; Dagostin MA; Fotis L; Bindoli S; Navarini L; Alibaz-Oner F; Sevik G; Frassi M; Ciccia F; Iacono D; Crisafulli F; Portincasa P; Jaber N; Kawakami-Campos PA; Wiesik-Szewczyk E; Iagnocco A; Simonini G; Sfriso P; Balistreri A; Giacomelli R; Conti G; Frediani B; Fabiani C; Cantarini L
Front Med (Lausanne); 2023; 10():1256243. PubMed ID: 38148914
[TBL] [Abstract][Full Text] [Related]
13. Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease in the U.S. Real-World Settings.
Hur P; Yi E; Ionescu-Ittu R; Manceur AM; Lomax KG; Cammarota J; Xie J; Gautam R; Nakasato P; Sanghera N; Kim N; Grom AA
Rheumatol Ther; 2022 Feb; 9(1):265-283. PubMed ID: 34874547
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?
Dall'Ara F; Frassi M; Tincani A; Airò P
Clin Rheumatol; 2016 Aug; 35(8):2117-2123. PubMed ID: 26758435
[TBL] [Abstract][Full Text] [Related]
15. A Case of Adult-Onset Still's Disease With Positive Antinuclear Antibodies and Positive Antineutrophil Cytoplasmic Antibodies.
Vasilev V; Savvina M; Argunova A; Danilova A
Cureus; 2024 May; 16(5):e61399. PubMed ID: 38953085
[TBL] [Abstract][Full Text] [Related]
16. Adding colchicine to immunosuppressive treatments; a potential option for biologics-refractory adult-onset Still's disease.
Asano T; Furuya MY; Sato S; Kobayashi H; Watanabe H; Suzuki E; Migita K
BMC Res Notes; 2018 May; 11(1):320. PubMed ID: 29784018
[TBL] [Abstract][Full Text] [Related]
17. Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review).
Junge G; Mason J; Feist E
Semin Arthritis Rheum; 2017 Oct; 47(2):295-302. PubMed ID: 28757235
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of biological agents in adult-onset Still's disease.
Cavalli G; Franchini S; Aiello P; Guglielmi B; Berti A; Campochiaro C; Sabbadini MG; Baldissera E; Dagna L
Scand J Rheumatol; 2015; 44(4):309-14. PubMed ID: 25656459
[TBL] [Abstract][Full Text] [Related]
19. A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.
Kadavath S; Zapantis E; Zolty R; Efthimiou P
Int J Rheum Dis; 2014 Mar; 17(3):336-40. PubMed ID: 24581387
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
